A new study published in Nature Communications offers rare insight into the brain activity of people experiencing major ...

Double-digit prescription gains for its commercial drugs, major coverage wins, and the early launch of a new migraine therapy were the most significant highlights. Despite substantial progress, the ...

Research and development (R&D) expenses were $49.5 million for the second quarter of 2025, compared to $49.9 million for the comparable period in 2024. The decrease was primarily related to the ...

Neumora is currently conducting preclinical DIO studies to characterize the potential of NMRA-215 in obesity and expects to report data in 2025. Additionally, Neumora expects to progress NMRA-215 into ...

Researchers discovered that PTSD may be driven by excess GABA from astrocytes, not neurons. This chemical imbalance disrupts ...

The province has had delays in delivering new programs and services, two years into the legally mandated program to move ...

A new study reveals that astrocyte-derived GABA, not neuronal activity, plays a central role in PTSD by impairing the brain’s ability to extinguish traumatic memories.

The Senate has approved large-scale spending legislation that includes provisions to allow U.S. Department of Veterans ...

An older woman with dementia and type 2 diabetes was started on semaglutide and subsequently developed severe psychological and physical symptoms, including apathy, significant weight loss and ...

Wondering what is trauma therapy for adults and if it’s right for you? This blog explains how it works, what it treats, and ...

Delivered $38.1 million total revenue in the quarter, representing 18% adjusted pro forma revenue growthGenerated record Greenbrook clinic revenue of $23.0 million in the quarterReduced cash used in ...

Expanding participation in ACO models among CHCs while improving their design can improve access to care and quality of care ...